• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺叶袖状切除术后伴或不伴阻塞性肺炎的非小细胞肺癌患者的诊断和预后价值

Diagnostic and prognostic values of NSCLC patients with or without obstructive pneumonia after sleeve lobectomy.

作者信息

Huang Yuxia, Zhang Lan, Zhang Wentian, Lv Na, Wang Tao

机构信息

Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Institute of Respiratory Diseases of Sun Yat-sen University, Guangzhou, China.

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

出版信息

Front Cell Infect Microbiol. 2024 Dec 16;14:1474998. doi: 10.3389/fcimb.2024.1474998. eCollection 2024.

DOI:10.3389/fcimb.2024.1474998
PMID:39735257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11682716/
Abstract

OBJECTIVE

We aimed to identify the diagnostic value of next-generation sequencing (NGS) of bronchoalveolar lavage fluid (BALF) from patients with non-small-cell lung cancer (NSCLC).

METHODS

Forty patients who were initially diagnosed with pulmonary nodules were enrolled. Frozen section histology was used to identify the NSCLC cell types. NGS of collected BALF samples was used for microbial identification. We compared the bacterial and viral distributions in BALF samples from patients with NSCLC with and without obstructive pneumonia as well as their NSCLC drainage times following surgery.

RESULTS

Of the 29 patients with NSCLC, eight had obstructive pneumonia. , , and were the top three bacteria present in almost 50% of patients, both with and without obstructive pneumonia. The viral detection rate was higher in the BALF of patients with NSCLC who did not have obstructive pneumonia. However, in patients with NSCLC and drain times of >5 days, the human herpes virus type 7 detection rate was higher following surgery than it was in patients with NSCLC who had drain times of ≤5 days.

CONCLUSION

Viral imbalance in NSCLC is closely related to the occurrence of obstructive pneumonia and postoperative drainage time.

摘要

目的

我们旨在确定非小细胞肺癌(NSCLC)患者支气管肺泡灌洗液(BALF)的下一代测序(NGS)的诊断价值。

方法

纳入40例最初诊断为肺结节的患者。采用冰冻切片组织学方法确定NSCLC细胞类型。对收集的BALF样本进行NGS用于微生物鉴定。我们比较了有和没有阻塞性肺炎的NSCLC患者BALF样本中的细菌和病毒分布以及他们术后的NSCLC引流时间。

结果

在29例NSCLC患者中,8例有阻塞性肺炎。在几乎50%有和没有阻塞性肺炎的患者中,[此处原文缺失具体细菌名称]、[此处原文缺失具体细菌名称]和[此处原文缺失具体细菌名称]是最常见的三种细菌。在没有阻塞性肺炎的NSCLC患者的BALF中病毒检测率更高。然而,在NSCLC且引流时间>5天的患者中,术后人类疱疹病毒7型检测率高于引流时间≤5天的NSCLC患者。

结论

NSCLC中的病毒失衡与阻塞性肺炎的发生和术后引流时间密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d77/11682716/8e988fae38ff/fcimb-14-1474998-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d77/11682716/198d00fcb138/fcimb-14-1474998-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d77/11682716/8e988fae38ff/fcimb-14-1474998-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d77/11682716/198d00fcb138/fcimb-14-1474998-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d77/11682716/8e988fae38ff/fcimb-14-1474998-g002.jpg

相似文献

1
Diagnostic and prognostic values of NSCLC patients with or without obstructive pneumonia after sleeve lobectomy.肺叶袖状切除术后伴或不伴阻塞性肺炎的非小细胞肺癌患者的诊断和预后价值
Front Cell Infect Microbiol. 2024 Dec 16;14:1474998. doi: 10.3389/fcimb.2024.1474998. eCollection 2024.
2
Diagnostic value of metagenomic next-generation sequencing using bronchoalveolar lavage fluid samples for pathogen detection in children with severe or refractory pneumonia.基于支气管肺泡灌洗液体样本的宏基因组二代测序在儿童重症或难治性肺炎病原体检测中的诊断价值
Microbiol Spectr. 2025 Mar 4;13(3):e0108724. doi: 10.1128/spectrum.01087-24. Epub 2025 Feb 4.
3
The clinical significance of simultaneous detection of pathogens from bronchoalveolar lavage fluid and blood samples by metagenomic next-generation sequencing in patients with severe pneumonia.宏基因组下一代测序同时检测重症肺炎患者支气管肺泡灌洗液和血液样本中的病原体的临床意义。
J Med Microbiol. 2021 Jan;70(1). doi: 10.1099/jmm.0.001259.
4
The Application of Metagenomic Next-Generation Sequencing in Detection of Pathogen in Bronchoalveolar Lavage Fluid and Sputum Samples of Patients with Pulmonary Infection.宏基因组下一代测序在检测肺部感染患者支气管肺泡灌洗液和痰液样本中的病原体中的应用。
Comput Math Methods Med. 2021 Nov 8;2021:7238495. doi: 10.1155/2021/7238495. eCollection 2021.
5
High utility of bronchoalveolar lavage fluid metagenomic next-generation sequencing approach for etiological diagnosis of pneumonia.支气管肺泡灌洗液宏基因组下一代测序方法在肺炎病因诊断中的高实用性。
BMC Infect Dis. 2024 Nov 2;24(1):1232. doi: 10.1186/s12879-024-10108-6.
6
The application value of targeted next-generation sequencing using bronchoalveolar lavage fluid samples in community-acquired pneumonia in children.支气管肺泡灌洗液体样本靶向二代测序在儿童社区获得性肺炎中的应用价值
J Infect Chemother. 2025 Mar;31(3):102610. doi: 10.1016/j.jiac.2025.102610. Epub 2025 Jan 10.
7
Diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in pediatric pneumonia.支气管肺泡灌洗液宏基因组下一代测序在儿童肺炎中的诊断价值。
Front Cell Infect Microbiol. 2022 Oct 27;12:950531. doi: 10.3389/fcimb.2022.950531. eCollection 2022.
8
Metagenomic next-generation sequencing targeted and metagenomic next-generation sequencing for pulmonary infection in HIV-infected and non-HIV-infected individuals.宏基因组下一代测序靶向检测与宏基因组下一代测序在 HIV 感染和非 HIV 感染个体肺部感染中的应用。
Front Cell Infect Microbiol. 2024 Aug 19;14:1438982. doi: 10.3389/fcimb.2024.1438982. eCollection 2024.
9
[Value of Pathogenic Detection by Next-Generation Sequencing in Bronchoalveolar Lavage Fluid on Children with Hematological Malignancies].[二代测序检测支气管肺泡灌洗液中病原体在儿童血液系统恶性肿瘤中的价值]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2025 Apr;33(2):569-574. doi: 10.19746/j.cnki.issn.1009-2137.2025.02.039.
10
Comparative analysis of metagenomic and targeted next-generation sequencing for pathogens diagnosis in bronchoalveolar lavage fluid specimens.宏基因组和靶向二代测序在支气管肺泡灌洗液标本中病原体诊断的比较分析。
Front Cell Infect Microbiol. 2024 Aug 27;14:1451440. doi: 10.3389/fcimb.2024.1451440. eCollection 2024.

本文引用的文献

1
The Influence of the Gut Microbiota on Host Health: A Focus on the Gut-Lung Axis and Therapeutic Approaches.肠道微生物群对宿主健康的影响:聚焦肠-肺轴及治疗方法
Life (Basel). 2024 Oct 9;14(10):1279. doi: 10.3390/life14101279.
2
Airway bacterial microbiome signatures correlate with occupational pneumoconiosis progression.气道细菌微生物组特征与职业性尘肺病进展相关。
Ecotoxicol Environ Saf. 2024 Oct 1;284:116875. doi: 10.1016/j.ecoenv.2024.116875. Epub 2024 Aug 13.
3
Lung microbiome: new insights into the pathogenesis of respiratory diseases.
肺部微生物组:呼吸系统疾病发病机制的新见解。
Signal Transduct Target Ther. 2024 Jan 17;9(1):19. doi: 10.1038/s41392-023-01722-y.
4
Streptococcus pneumoniae promotes lung cancer development and progression.肺炎链球菌促进肺癌的发生和发展。
iScience. 2023 Jan 4;26(2):105923. doi: 10.1016/j.isci.2022.105923. eCollection 2023 Feb 17.
5
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.癌症患者接受免疫疗法或免疫肿瘤学联合治疗后的完全缓解:MOUSEION-03 荟萃分析。
Cancer Immunol Immunother. 2023 Jun;72(6):1365-1379. doi: 10.1007/s00262-022-03349-4. Epub 2023 Jan 12.
6
The research progress in the interaction between and cancers.[此处原文不完整,缺少关键内容]与癌症之间相互作用的研究进展。
Front Microbiol. 2022 Sep 28;13:988734. doi: 10.3389/fmicb.2022.988734. eCollection 2022.
7
Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate.确定高程序性死亡配体1(PD-L1)表达的晚期非小细胞肺癌的最佳一线治疗方案:一个存在争议的问题。
Br J Cancer. 2022 Nov;127(8):1381-1382. doi: 10.1038/s41416-022-01929-w. Epub 2022 Sep 5.
8
Influenza Vaccination and Risk of Lung Cancer in Patients with Chronic Kidney Disease: A Nationwide, Population-Based Cohort Study.慢性肾脏病患者的流感疫苗接种与肺癌风险:一项基于全国人口的队列研究
Cancers (Basel). 2022 Jun 14;14(12):2926. doi: 10.3390/cancers14122926.
9
Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.质子泵抑制剂和组胺-2受体拮抗剂对非小细胞肺癌免疫治疗的影响:一项系统评价和荟萃分析
Cancers (Basel). 2022 Mar 9;14(6):1404. doi: 10.3390/cancers14061404.
10
Oral Microbiota-A New Frontier in the Pathogenesis and Management of Head and Neck Cancers.口腔微生物群——头颈癌发病机制与治疗的新前沿
Cancers (Basel). 2021 Dec 23;14(1):46. doi: 10.3390/cancers14010046.